Summit (TM) 2.0 is a CSF-based liquid biopsy assay designed to enable comprehensive genomic profiling for characterization of CNS tumors. CNS malignancies present unique diagnostic challenges, as ...

Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological ...

How Is a CSF Glucose Test Done? The most common way to check the glucose in your cerebrospinal fluid is by performing a lumbar puncture, also called a spinal tap. In some cases, your doctor can also ...

The two firms are teaming to develop and commercialize a rapid test for detecting cerebrospinal fluid.NeuroPro Technologies Inc., a 5-year-old firm promoted by neurosurgeons in Modesto, Calif., today ...

IDH mutation status impact on in vivo hypoxia biomarkers expression: New insights from a clinical, nuclear imaging, and immunohistochemical study in 34 patients with glioma. Background: Cerebrospinal ...

A team of researchers from Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College used genetic testing of cells found in cerebrospinal fluid to track certain brain tumors. In their ...

It is not possible to test for a cerebrospinal fluid (CSF) leak at home. However, knowing the possible symptoms of a CSF leak can help a person know when to seek emergency help to receive a diagnosis ...

A test that looks for genetic hallmarks of brain cancers in samples of cerebrospinal fluid can decrease the time to diagnosis and eliminate the need for invasive brain biopsies for some patients.

Brain fluid started leaking from a woman's nose after she was swabbed for COVID-19 testing as the extra-long Q-tips caused 'trauma' to pre-existing defect in the woman's skull. The University of Iowa ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A rare case of cerebrospinal fluid (CSF) leak occurred after a healthcare worker inadvertently ...

Belay Diagnostics, an innovative CLIA/CAP accredited laboratory focused on the development and commercialization of molecular diagnostics targeting central nervous system (CNS) cancers, announced the ...